Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma

Completed · Phase 2

Conditions studied: Neuroblastoma

In brief

RATIONALE: Drugs used in chemotherapy, such as irinotecan and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving irinotecan together with temozolomide works in treating young patients with recurrent neuroblastoma.

Key facts

Study ID
NCT00311584
Run by
Children's Oncology Group
People needed
59
Starts
2006-04-01
Expected to finish
2013-12-01
Last updated by the study team
2014-09-30

Who can join

Age: any, up to 21. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.